Anyway, @Mason14 doesn't know how expensive it is to purchase IP with massive potential. That's probably why RAC hasn't purchase any additional IP, IMU might become RAC with MC of $200M and only have HER-Vaxx to develop if all of VAXINIA/OASIS and Azer-Cel does fail but at least HER-Vaxx has completed Ph2 clinical trial with very promising results.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.002(10.7%) |
Mkt cap ! $93.33M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $167.5K | 13.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 54 | 14898285 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 6732178 | 23 |
View Market Depth
| Last trade - 14.13pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |